An open label, single centre, assessor blind pilot study comparing topical tacrolimus 0.1% and hydrocortisone ointment 1% in the treatment of flexural psoriasis

Belfast City Hospital0 个研究点目标入组 20 人开始时间: 2005年7月11日最近更新: 2019年12月16日

适应症

试验速览

暂无简介。

•- Subjects with diagnosis of flexural psoriasis and aged 18 or above
•- Subjects who demonstrate willingness to participate in the study and comply with its procedures by signing a written informed consent
•- women of childbearing potential who are prepared to use an acceptable method of birth control during the study and have a negative urine pregnancy test prior to study entry.
•Are the trial subjects under 18? no
•Number of subjects for this age range:
•F.1.2 Adults (18-64 years) yes
•F.1.2.1 Number of subjects for this age range
•F.1.3 Elderly (>=65 years) no
•F.1.3.1 Number of subjects for this age range

•- Female subjects who are pregnant or breast feeding.
•- Subjects who have received treatment for flexural psoriasis 2 weeks prior to study entry.
•- Subjects currently receiving immunosuppressive drugs.
•- Subjects who have had a previous reaction to tacrolimus or its constituents
•- Patient is simultaneously participating in any other clinical trial
•- any form of substance abuse, psychiatric disorder or condition which may invalidate communication with the investigator.

发起方

Belfast City Hospital